People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...
The long-term goal of a fully automated insulin delivery (AID) system that operates without user input to maintain glucose levels within target range remains a future aspiration and may never be fully ...
From adaptive brain stimulators to self-monitoring orthopedic implants, researchers are building intelligent medical devices that sense, decide, and treat, closing the loop between diagnosis and ...